Oncology Need for non-melanoma skin cancer guideline never greater Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, more than breast, bowel, and prostate cancer combined.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.